Related Experiment Video
Updated: Aug 10, 2026
09:22
In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
Published on: January 2, 2015
Tau protein and neurodegeneration
1Medical Research Council Laboratory of Molecular Biology, Hills Road, Cambridge CB2 2QH, UK. mg@mrc-lmb.cam.ac.uk
Seminars in Cell & Developmental Biology
|March 24, 2004
Summary
Tau protein aggregates cause neurodegenerative diseases like Alzheimer's. Mutations in Tau confirm its dysfunction leads to dementia, aiding new animal models for tauopathies.
Area of Science:
- Neuroscience
- Genetics
- Pathology
Background:
- Tau protein forms intracellular deposits in neurodegenerative diseases.
- These tauopathies include Alzheimer's disease, PSP, CBD, PiD, and FTDP-17.
Purpose of the Study:
- To establish the causal link between Tau protein dysfunction and neurodegeneration.
- To explore the genetic basis of inherited tauopathies.
Main Methods:
- Genetic analysis of familial frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).
- Investigating the role of Tau mutations in disease pathogenesis.
- Development of transgenic animal models.
Main Results:
- Identification of Tau mutations as the cause of FTDP-17.
- Demonstrated that Tau protein dysfunction is sufficient to cause neurodegeneration and dementia.
- Successful creation of animal models for studying tauopathies.
Conclusions:
- Tau protein dysfunction is a key driver of neurodegeneration in tauopathies.
- Genetic factors, specifically Tau mutations, can directly cause dementia.
- Transgenic models offer promising avenues for experimental research into these diseases.
More Related Videos
Related Concept Videos
01:00Enzyme-linked Receptors
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:48ATP Synthase: Mechanism
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...